UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats

Journal of bone and mineral metabolism, 2017-03, Vol.35 (2), p.142-149

2017

Link zum Volltext

Verfügbarkeit prüfen

FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats

Hormones and behavior, 2016-09, Vol.85, p.86-95

2016

Link zum Volltext

Verfügbarkeit prüfen

Potential roles of fibroblast growth factor 21 in the brain

Metabolic Brain Disease, 2016-04, Vol.31 (2), p.239-248

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: a randomized controlled trial

The international journal of behavioral nutrition and physical activity, 2024-03, Vol.21 (1), p.28-28, Article 28

2024

Link zum Volltext

Verfügbarkeit prüfen

Effects of Exercise Rehabilitation on Cardiorespiratory Fitness in Long-COVID-19 Survivors: A Meta-Analysis

Journal of clinical medicine, 2024-06, Vol.13 (12), p.3621

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term impact of SARS-CoV-2 infection on cardiorespiratory fitness: a meta-analysis

Frontiers in public health, 2023-10, Vol.11, p.1215486-1215486

2023

Link zum Volltext

Verfügbarkeit prüfen

Partial involvement of Nrf2 in skeletal muscle mitohormesis as an adaptive response to mitochondrial uncoupling

Scientific reports, 2018-02, Vol.8 (1), p.2446-12, Article 2446

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparing the 6-minute Walk Test Performance and Estimated Maximal Oxygen Consumption Between Physically Active and Inactive Obese Young Adults

Physical Activity and Health, 2024-03, Vol.8 (1), p.20-28

2024

Link zum Volltext

Verfügbarkeit prüfen

COMPARATIVE EFFECTS OF DDP4 INHIBITOR AND SGLT2 INHIBITOR ON BRAIN FUNCTION UNDER OBESE-INSULIN RESISTANT CONDITION

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P948-P949

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase‐4 inhibitor in prediabetic rats

Cardiovascular therapeutics, 2017-08, Vol.35 (4), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats

Toxicology and applied pharmacology, 2017-10, Vol.333, p.43-50

2017

Link zum Volltext

Verfügbarkeit prüfen

Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions

Hormones and behavior, 2015-06, Vol.72, p.68-77

2015

Link zum Volltext

Verfügbarkeit prüfen

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats

Biomedicine & pharmacotherapy, 2018-01, Vol.97, p.1663-1672

2018

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: the different roles of FGF21

Scientific reports, 2018-03, Vol.8 (1), p.5174-9, Article 5174

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of sex hormone deprivation on the brain of insulin-resistant rats

Journal of endocrinology, 2019-04, Vol.241 (1), p.1-15

2019

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats

Menopause (New York, N.Y.), 2016-08, Vol.23 (8), p.894

2016

Link zum Volltext

Verfügbarkeit prüfen

Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats

British journal of nutrition, 2016-11, Vol.116 (10), p.1700-1708

2016

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance

Archives of oral biology, 2018-01, Vol.85, p.148-153

2018

Link zum Volltext

Verfügbarkeit prüfen

Testosterone deprivation has neither additive nor synergistic effects with obesity on the cognitive impairment in orchiectomized and/or obese male rats

Metabolism, clinical and experimental, 2016-02, Vol.65 (2), p.54-67

2016

Link zum Volltext

Verfügbarkeit prüfen

P3‐252: FGF 21 IS ONE OF THE FACTORS ASSOCIATED WITH COGNITIVE DECLINE IN NONELDERLY PATIENTS WITH METABOLIC SYNDROME

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_22), p.P1170-P1171

2018

Link zum Volltext

Verfügbarkeit prüfen

FGF 21 IS ONE OF THE FACTORS ASSOCIATED WITH COGNITIVE DECLINE IN NONELDERLY PATIENTS WITH METABOLIC SYNDROME

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P1170-P1171

2018

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats

Menopause (New York, N.Y.), 2017-07, Vol.24 (7), p.850

2017

Link zum Volltext

Verfügbarkeit prüfen

Protocatechuic acid protects brain mitochondrial function in streptozotocin-induced diabetic rats

Applied physiology, nutrition, and metabolism, 2015-10, Vol.40 (10), p.1078

2015

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats

Canadian journal of diabetes, 2018-10, Vol.42 (5), p.545-552

2018

Link zum Volltext

Verfügbarkeit prüfen

Obstructive Sleep Apnea Effects on Pulmonary and Respiratory Muscle Function of Obese Children and Adolescents: A Preliminary Study

Turkish Thoracic Journal, 2022-03, Vol.23 (2), p.104-108

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Animals
(15)
Insulin Resistance
(14)
Rats, Wistar
(12)
Rats
(11)
Male
(10)
Obesity
(10)
Diet, High-Fat
(9)
Mitochondria
(9)
Obesity - Physiopathology
(8)
Rodents
(8)
Endocrinology & Metabolism
(7)
Obesity - Complications
(7)
Oxidative Stress
(7)
Brain
(6)
Female
(6)
Dipeptidyl-Peptidase Iv Inhibitors - Pharmacology
(5)
Metabolic Syndrome
(5)
Obesity - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats

FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats

Potential roles of fibroblast growth factor 21 in the brain

Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: a randomized controlled trial

Effects of Exercise Rehabilitation on Cardiorespiratory Fitness in Long-COVID-19 Survivors: A Meta-Analysis

Long-term impact of SARS-CoV-2 infection on cardiorespiratory fitness: a meta-analysis

Partial involvement of Nrf2 in skeletal muscle mitohormesis as an adaptive response to mitochondrial uncoupling

Comparing the 6-minute Walk Test Performance and Estimated Maximal Oxygen Consumption Between Physically Active and Inactive Obese Young Adults

COMPARATIVE EFFECTS OF DDP4 INHIBITOR AND SGLT2 INHIBITOR ON BRAIN FUNCTION UNDER OBESE-INSULIN RESISTANT CONDITION

Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase‐4 inhibitor in prediabetic rats

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats

Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: the different roles of FGF21

Comparative effects of sex hormone deprivation on the brain of insulin-resistant rats

Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats

Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats

Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance

Testosterone deprivation has neither additive nor synergistic effects with obesity on the cognitive impairment in orchiectomized and/or obese male rats

P3‐252: FGF 21 IS ONE OF THE FACTORS ASSOCIATED WITH COGNITIVE DECLINE IN NONELDERLY PATIENTS WITH METABOLIC SYNDROME

FGF 21 IS ONE OF THE FACTORS ASSOCIATED WITH COGNITIVE DECLINE IN NONELDERLY PATIENTS WITH METABOLIC SYNDROME

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats

Protocatechuic acid protects brain mitochondrial function in streptozotocin-induced diabetic rats

Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats

Obstructive Sleep Apnea Effects on Pulmonary and Respiratory Muscle Function of Obese Children and Adolescents: A Preliminary Study

Suchergebnisse filtern